相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Interval dynamics of transplantability for hepatocellular carcinoma after primary curative resection: risk factors for nontransplantable recurrence
Hou-Ying Cheng et al.
HPB (2023)
Towards a new definition of decompensated cirrhosis
Gennaro D'Amico et al.
JOURNAL OF HEPATOLOGY (2022)
Improved prognosis of hepatitis C-related hepatocellular carcinoma in the era of direct-acting antivirals
Tsuyoshi Fukumoto et al.
HEPATOLOGY COMMUNICATIONS (2022)
The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma
Yu-Syuan Chen et al.
MEDICINA-LITHUANIA (2022)
Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria
Hironori Ochi et al.
JOURNAL OF GASTROENTEROLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Survival After Treatable Hepatocellular Carcinoma Recurrence in Liver Recipients: A Nationwide Cohort Analysis
Cheng-Maw Ho et al.
FRONTIERS IN ONCOLOGY (2021)
Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside
Don C. Rockey et al.
GASTROENTEROLOGY (2021)
Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Therapy with Direct-Acting Antivirals. A Systematic Review and Meta-Analysis
Leonardo Frazzoni et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data
Chun-Ming Hong et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
Hepatic benefits of HCV cure
Vincenza Calvaruso et al.
JOURNAL OF HEPATOLOGY (2020)
2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population
Ming-Lung Yu et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2020)
Surgical outcomes for hepatocellular carcinoma detected after hepatitis C virus eradiation by direct-acting antivirals
Shogo Tanaka et al.
JOURNAL OF SURGICAL ONCOLOGY (2020)
EASL recommendations on treatment of hepatitis C: Final update of the series
Jean-Michel Pawlotsky et al.
JOURNAL OF HEPATOLOGY (2020)
Variable selection strategies and its importance in clinical prediction modelling
Mohammad Ziaul Islam Chowdhury et al.
FAMILY MEDICINE AND COMMUNITY HEALTH (2020)
Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma
Derek J. Erstad et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
Giuseppe Cabibbo et al.
JOURNAL OF HEPATOLOGY (2019)
Impact of Direct Acting Antiviral Agent Therapy upon Extrahepatic Manifestations of Hepatitis C Virus Infection
Arpan Mohanty et al.
CURRENT HIV/AIDS REPORTS (2019)
What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?
George N. Ioannou et al.
GASTROENTEROLOGY (2019)
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study
Amit G. Singal et al.
GASTROENTEROLOGY (2019)
Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy
Mizuki Nishibatake Kinoshita et al.
JOURNAL OF HEPATOLOGY (2019)
Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study
Antonietta Romano et al.
JOURNAL OF HEPATOLOGY (2018)
Managing hepatitis C in patients with the complications of cirrhosis
Marcus M. Muecke et al.
LIVER INTERNATIONAL (2018)
Long-Term Prognostic Factors after Hepatic Resection for Hepatitis C Virus-Related Hepatocellular Carcinoma, with a Special Reference to Viral Status
Masaki Koda et al.
LIVER CANCER (2018)
Achieving hepatitis C elimination in Taiwan-Overcoming barriers by setting feasible strategies
Grace Hui-Min Wu et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2018)
Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis
Silvia Martini et al.
LIVER INTERNATIONAL (2017)
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
Pierre Nahon et al.
GASTROENTEROLOGY (2017)
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
Reem Waziry et al.
JOURNAL OF HEPATOLOGY (2017)
Risk factors of early recurrence after curative hepatectomy in hepatocellular carcinoma
Young Mi Hong et al.
TUMOR BIOLOGY (2017)
Hepatitis C virus infection
Michael P. Manns et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents
George Cholankeril et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2017)
APASL consensus statements and recommendation on treatment of hepatitis C
Masao Omata et al.
HEPATOLOGY INTERNATIONAL (2016)
Direct acting antivirals for decompensated cirrhosis. Efficacy and safety are now established
Michael P. Curry
JOURNAL OF HEPATOLOGY (2016)
Reversion of disease manifestations after HCV eradication
Adriaan J. van der Meer et al.
JOURNAL OF HEPATOLOGY (2016)
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2016)
Hepatitis C virus infection in Taiwan: Past, present, and future
Jia-Horng Kao
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2016)
Recurrence of Hepatocellular Cancer After Resection Patterns, Treatments, and Prognosis
Parissa Tabrizian et al.
ANNALS OF SURGERY (2015)
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach-The ALBI Grade
Philip J. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection
Yao-Chun Hsu et al.
GUT (2015)
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma A Meta-analysis of Observational Studies
Rebecca L. Morgan et al.
ANNALS OF INTERNAL MEDICINE (2013)
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
Richard Moreau et al.
GASTROENTEROLOGY (2013)
Long-Term Outcomes After Resection Versus Transplantation for Hepatocellular Carcinoma Within UCSF Criteria
Cheng-Maw Ho et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
Adriaan J. van der Meer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer
D. R. McGivern et al.
ONCOGENE (2011)
Timing of Hepatitis C Antiviral Therapy in Patients with Advanced Liver Disease: A Decision Analysis Model
Sammy Saab et al.
LIVER TRANSPLANTATION (2010)
Pegylated interferon α-2a versus standard interferon α-2a for treatment-naive dialysis patients with chronic hepatitis C:: a randomised study
C-H Liu et al.
GUT (2008)
What patients can survive disease free after complete resection for hepatocellular carcinoma?: A multivariate analysis
M Takata et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2000)